Clinical Trial: Application of MRI-Based Assessment of Lesion Spatial Heterogeneity and Response to Neoadjuvant Chemotherapy in Cervical Cancer Subtyping (China)

Posted On: 2026-10-29

China, Oct. 29 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Application of MRI-Based Assessment of Lesion Spatial Heterogeneity and Response to Neoadjuvant Chemotherapy in Cervical Cancer Subtyping'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600135372

Registration Time: 2026/10/29

Type: Observational study

Primary Sponsor: The First Affiliated Hospital of Chongqing Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=322349

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Application of MRI-Based Assessment of Lesion Spatial Heterogeneity and Response to Neoadjuvant Chemotherapy in Cervical Cancer Subtyping (China)